Precision Fermented Egg White Protein Market Size, Growth, Trends and Forecast 2026-2035

Precision Fermented Egg White Protein Market Size and Overview

The precision fermented egg white protein market was valued at USD 50.6 million in 2025 and is projected to reach USD 630.86 million by 2035, growing at a CAGR of 28.7% from 2026 to 2035. The market is driven by increasing demand for animal-free protein ingredients, rising interest in sustainable food production, and the need for alternatives to conventional eggs amid supply disruptions and price volatility. Advances in precision fermentation are enabling manufacturers to produce functional egg-white proteins, particularly ovalbumin, for applications across bakery products, confectionery, beverages, nutritional products and meat alternatives. Growing commercial interest is encouraging companies to expand production capacity, secure manufacturing partnerships and introduce consumer-facing products. In November 2025, The EVERY Company raised USD 55 million in Series D funding, led by McWin Capital Partners, to accelerate manufacturing expansion and commercial growth of its precision-fermented egg proteins.

Precision Fermented Egg White Protein Market Key Takeaways

• North America dominated the global precision fermentation egg white protein market in 2025, accounting for an estimated 50.0% share, followed by Europe at 35.0%, supported by early commercialization of precision-fermented ingredients, established food technology companies, and investment in alternative protein production.
• Sports and Nutritional Supplements are projected to be among the fastest-growing application segments, with an indicative CAGR of 35.0% during 2025–2035, driven by demand for animal-free protein ingredients, high-protein formulations, and alternative sources of functional nutrition.
• Asia-Pacific is projected to be the fastest-growing regional market, with an indicative CAGR of 36.5% during 2025–2035, supported by expanding alternative protein investments, food technology development, and growing demand for sustainable food ingredients.
• July 2026: The EVERY Company and ADM advanced their commercial production partnership for OvoPro, a precision-fermented egg white protein, at ADM's Iowa facility, reflecting continued investment in scaling animal-free egg protein manufacturing.

Precision Fermented Egg White Protein Market Trends & Disruptions Impacting Customers

Consumer demand is shifting towards animal-free protein ingredients that retain the functional properties of conventional egg whites, particularly in bakery and confectionery applications. In March 2026, The EVERY Company partnered with Healthier Comforts to introduce an animal-free egg white protein powder for household baking. The product targets applications such as meringues, macarons and angel food cakes, expanding the availability of precision-fermented egg white ingredients beyond industrial food manufacturing to household consumers. 

The expansion of precision-fermented egg white protein into retail channels also introduces new considerations around consumer acceptance, product pricing and ingredient labelling. Its adoption will depend on whether manufacturers can demonstrate comparable performance, competitive cost-in-use and clear product information to consumers. These factors will influence purchasing decisions among household bakers and food brands considering animal-free egg white alternatives.

Precision Fermented Egg White Protein Market Dynamics 

Driver Impact Analysis

Egg processors seek resilient protein inputs amid recurring supply disruptions.

Recurring poultry disease outbreaks and fluctuations in conventional egg availability are encouraging food manufacturers to explore alternative protein inputs. In February 2026, USDA reported that the US egg industry lost 41.8 million laying hens to highly pathogenic avian influenza during 2025, while annual table egg production declined 4.6% year-on-year to 7,382 million dozen. These supply disruptions increase procurement uncertainty for egg processors and commercial food manufacturers. Precision-fermented egg white proteins offer an alternative production route independent of poultry farming, creating opportunities to diversify ingredient sourcing and improve supply resilience.

Restraint Impact Analysis

Fermentation scale-up and purification increase manufacturing complexity for new producers.

Commercial production of precision-fermented egg white protein requires specialized fermentation infrastructure, optimized microbial strains and downstream purification processes to achieve consistent protein quality and functional performance. Increasing production volumes while maintaining purity, yield and batch consistency adds operational complexity and capital requirements. These challenges are particularly significant for new producers transitioning from pilot-scale production to industrial manufacturing. Limited production capacity can further restrict dependable bulk ingredient availability for multinational food manufacturers, delaying supplier qualification, formulation trials and wider commercial adoption.

Precision Fermented Egg White Protein Market: Commercial Use Cases Across Industries

COMPANY	USE CASE DESCRIPTION	BENEFITS
	Supplies Bioalbumen, a precision-fermented ovalbumin ingredient, for high-protein breakfast products. In September 2026, Onego Bio entered into a commercial partnership with Zen Waffles to incorporate Bioalbumen into its high-protein waffle products.	Improves waffle structure, tenderness and browning while providing animal-free egg protein functionality. Enables breakfast food manufacturers to develop protein-enriched products with consistent ingredient performance.
	Develops OvoPro, a precision-fermented egg white protein ingredient for bakery, confectionery, frozen and prepared foods, pasta and protein bars. The ingredient replicates the binding, gelling, foaming and whipping properties of conventional egg whites.	Enables food manufacturers to replace conventional egg ingredients while maintaining product texture, structure and functionality. Provides greater ingredient supply consistency and formulation flexibility.

Market Ecosystem

The global precision fermented egg white protein market ecosystem connects fermentation technology developers, microbial strain developers, precision fermentation ingredient manufacturers, food-grade media and nutrient suppliers, downstream purification and processing equipment providers, ingredient distributors, food manufacturers, regulatory authorities and end-product brands. The ecosystem covers microbial strain development, fermentation, protein recovery, purification, drying, formulation, quality testing and commercial ingredient distribution. Major market participants include The EVERY Company, Onego Bio, Fooditive Group, The Protein Brewery, and other emerging precision fermentation companies, with applications spanning bakery and confectionery, food processing, meat alternatives, dairy alternatives, beverages and nutritional products.

Developments across the ecosystem are strengthening commercial manufacturing capacity, strategic partnerships and access to fermentation infrastructure. In June 2026, The EVERY Company partnered with Huvepharma to quadruple its production capacity for OvoPro™, responding to annual orders secured during the first four months of 2026 that represented 550% of its total 2025 order volume. In November 2025, EVERY also raised US$55 million in Series D funding to expand manufacturing capacity and accelerate commercial supply to multinational food customers. These developments reflect the growing importance of manufacturing partnerships, production scale and investment in establishing a reliable supply of precision-fermented egg white protein for food manufacturers.

Precision Fermented Egg White Protein Market Segment Analysis         

By Form

Powder-based precision-fermented egg white proteins are gaining commercial traction due to their longer shelf life, convenient transportation and suitability for industrial food formulations. In March 2026, The EVERY Company partnered with Healthier Comforts to introduce its OvoPro™-based animal-free egg white protein powder in an 8-ounce retail-ready package, making the ingredient available to household consumers through its website and Amazon. The launch expands precision-fermented egg white protein beyond bulk B2B ingredient sales into consumer baking applications, including meringues, macarons and cakes.

By Application

Bakery and confectionery applications represent a key commercial opportunity for precision-fermented egg white proteins due to their foaming, whipping, binding and gelling properties. In September 2025, Onego Bio received an FDA no-questions letter for Bioalbumen®, covering its use as a dietary protein and functional ingredient in baked goods, beverages, meat analogues, confections and sauces. These applications enable manufacturers to incorporate fermentation-derived ovalbumin into existing formulations while retaining important product characteristics, expanding its potential use across commercial bakeries, packaged food manufacturers and foodservice businesses.

Precision Fermented Egg White Protein Market Geographical Penetration

North America’s Precision Fermented Egg White Protein Market Leadership Is Reinforced by Commercial Manufacturing Investments and Ingredient Innovation

North America dominated the global precision fermented egg white protein market in 2025, supported by early commercialization, food biotechnology investments and the presence of emerging ingredient manufacturers. The United States is a key market for precision-fermented egg white proteins, driven by demand from bakery, confectionery and packaged food manufacturers seeking alternatives to conventional egg ingredients. In March 2025, Onego Bio selected Jefferson County, Wisconsin, for its flagship Bioalbumen manufacturing facility, purchasing 25.9 acres within the county's Food and Beverage Innovation Campus. The proposed facility is designed to produce fermentation-derived egg protein equivalent to the output of approximately 6 million laying hens, highlighting the region's growing focus on industrial-scale alternative egg protein manufacturing. 

The region's position is further reinforced by its established food ingredient manufacturing infrastructure, access to fermentation technology and growing commercialization capabilities. The presence of companies such as The EVERY Company and Onego Bio is strengthening the domestic supply base for fermentation-derived ovalbumin and other egg-white proteins. Their activities across ingredient development, food application testing and manufacturing expansion are creating opportunities to integrate precision-fermented proteins into established food processing and distribution networks, particularly in the United States.

Precision Fermented Egg White Protein Market BCG Matrix: Company Evaluation

The precision fermented egg white protein market is currently positioned in the potential quadrant of the BCG matrix, reflecting its high growth potential but relatively limited commercial penetration compared with conventional egg white proteins. Ovalbumin represents the strongest emerging product category, supported by commercial launches and increasing food manufacturer interest. Powder-based ingredients and bakery applications demonstrate early commercial traction, while liquid and specialized protein formats remain at earlier stages of adoption. Companies such as The EVERY Company and Onego Bio are investing in production expansion and commercial partnerships to strengthen their market positions. As manufacturing capacity, cost competitiveness and consumer acceptance improve, leading suppliers have opportunities to transition emerging product categories towards the Star quadrant.

Precision Fermented Egg White Protein Market Competitive Landscape

Key Market Player

• Onego Bio
• The EVERY Company

Precision Fermented Egg White Protein Market Scope

Precision Fermented Egg White Protein Market: Target Audience and Strategic Intelligence Requirements

Addressing Client Priorities Through Customized Precision Fermented Egg White Protein Research

Key Developments

• March 2025: Onego Bio selected Jefferson County, Wisconsin, for its flagship Bioalbumen manufacturing facility, dedicated to producing precision-fermented egg-white protein. The planned facility is intended to expand US production capacity and supply food manufacturers.
• March 2025: The EVERY Company partnered with Earthbar to launch Protein Mocha Latte and Protein Matcha Latte across selected California locations, each containing 12–13 grams of protein using EVERY's precision-fermented egg protein. The launches introduced fermentation-derived egg protein into ready-to-consume beverages.
• September 2025: The US FDA issued a No Questions Letter for Onego Bio's GRAS Notice covering Bioalbumen, its precision-fermented ovalbumin. The regulatory milestone allows its use under specified conditions in applications including baked goods, beverages, meat analogues, confectionery and sauces.
• November 2025: The EVERY Company raised US$55 million in Series D funding led by McWin Capital Partners, with participation from Main Sequence, Bloom8 and other investors. The funding strengthens the company's ability to expand manufacturing and commercialise its precision-fermented egg proteins.
• March 2026: Onego Bio entered a collaboration with Sigma Foods to advance egg protein innovation and evaluate Bioalbumen's commercial applications. The partnership focuses on developing food applications and improving the resilience of egg protein supply.
• March 2026: The EVERY Company partnered with Healthier Comforts to introduce an animal-free egg-white protein powder powered by OvoPro. The product's launch through direct-to-consumer channels expanded access to precision-fermented egg protein for home cooking and food preparation.
• June 2026: The EVERY Company partnered with Huvepharma to quadruple its OvoPro manufacturing capacity through Biovet AD's fermentation infrastructure in Bulgaria. The expansion followed orders secured during January–April 2026 that represented 550% of EVERY's total 2025 order volume.
• July 2026: The EVERY Company partnered with ADM to establish commercial-scale production of OvoPro at ADM's Clinton, Iowa facility. The agreement expands US manufacturing infrastructure for precision-fermented ovalbumin and strengthens supply capabilities for food manufacturers.
• September 2026: Onego Bio entered a commercial partnership with Zen Waffles to introduce Bioalbumen into high-protein breakfast products. The collaboration extends precision-fermented ovalbumin into the waffle category and broadens its food application base.